Powder: -20°C for 3 years
In solvent: -80°C for 2 years
KPLH1130 improves glucose tolerance in HFD-fed mice. KPLH1130 is a specific pyruvate <a href="/target/Dehydrogenase" style="display: inline; color: #c13a36">Dehydrogenase</a> kinase (<a href="/target/PDK" style="display: inline; color: #c13a36">PDK</a>) inhibitor, blocks macrophage polarization and attenuates proinflammatory responses.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 81.00 | |
5 mg | In stock | $ 231.00 | |
10 mg | In stock | $ 369.00 | |
25 mg | In stock | $ 693.00 | |
50 mg | In stock | $ 1,057.00 | |
100 mg | In stock | $ 1,462.00 | |
200 mg | In stock | $ 2,193.00 |
Description | KPLH1130 improves glucose tolerance in HFD-fed mice. KPLH1130 is a specific pyruvate dehydrogenase kinase (PDK) inhibitor, blocks macrophage polarization and attenuates proinflammatory responses. |
Molecular Weight | 283.28 |
Formula | C15H13N3O3 |
CAS No. | 906669-07-6 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
DMSO: 130 mg/mL (458.91 mM), Need ultrasonic
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KPLH1130 906669-07-6 Metabolism PI3K/Akt/mTOR signaling Dehydrogenase PDK KPLH 1130 Pyruvate dehydrogenase kinase PDH kinase KPLH-1130 inhibit Inhibitor PDHK inhibitor